Pfizer/Boehringer Ingelheim’s Spiriva Linked To Stroke In FDA MedWatch Alert
This article was originally published in The Pink Sheet Daily
Executive Summary
Pooled analyses of data on COPD treatment show increased risk of stroke in two patients per 1,000, agency says.